| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.14 | 0.005 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.097 | 0.03 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.074 | 0.1 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.059 | 0.2 |